Hypertension in mice lacking the gene for endothelial nitric oxide synthase

Nature
P L HuangM C Fishman

Abstract

Nitric oxide (NO), a potent vasodilator produced by endothelial cells, is thought to be the endothelium-dependent relaxing factor (EDRF) which mediates vascular relaxation in response to acetylcholine, bradykinin and substance P in many vascular beds. NO has been implicated in the regulation of blood pressure and regional blood flow, and also affects vascular smooth-muscle proliferation and inhibits platelet aggregation and leukocyte adhesion. Abnormalities in endothelial production of NO occur in atherosclerosis, diabetes and hypertension. Pharmacological blockade of NO production with arginine analogues such as L-nitroarginine (L-NA) or L-N-arginine methyl ester affects multiple isoforms of nitric oxide synthase (NOS), and so cannot distinguish their physiological roles. To study the role of endothelial NOS (eNOS) in vascular function, we disrupted the gene encoding eNOS in mice. Endothelium-derived relaxing factor activity, as assayed by acetylcholine-induced relaxation, is absent, and the eNOS mutant mice are hypertensive. Thus eNOS mediates basal vasodilation. Responses to NOS blockade in the mutant mice suggest that non-endothelial isoforms of NOS may be involved in maintaining blood pressure.

References

Jan 1, 1992·Neuroscience·S R Vincent, H Kimura
Nov 1, 1990·British Journal of Pharmacology·D D ReesS Moncada
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D D ReesS Moncada
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·J GenestP Hamet
Dec 30, 1993·The New England Journal of Medicine·S Moncada, A Higgs
Jan 1, 1994·Methods in Enzymology·J M Hevel, M A Marletta
Jan 1, 1994·Methods in Enzymology·U FörstermannM Nakane
Jan 1, 1994·Annual Review of Biochemistry·D S Bredt, S H Snyder
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·K IrikuraM A Moskowitz
Mar 1, 1995·Circulation Research·T MatsudaM W Chapleau
Dec 8, 1994·Nature·S H Snyder

❮ Previous
Next ❯

Citations

Feb 24, 2000·The Journal of Pathology·H Li, U Förstermann
Mar 1, 2000·Molecular Reproduction and Development·A Jablonka-Shariff, L M Olson
Aug 24, 1999·European Journal of Immunology·W NiedbalaF Y Liew
Sep 20, 2005·Journal of Clinical Laboratory Analysis·Asli CurgunluCemil Tascioglu
Mar 29, 2002·Journal of Cellular Physiology·Akira AndoPeter A Campochiaro
Dec 11, 2002·The Journal of Pathology·Ester W J A AlbrechtHarry van Goor
Oct 12, 2000·Biochemical and Biophysical Research Communications·S KawachiM B Grisham
Jun 11, 2002·Journal of Molecular and Cellular Cardiology·Koichi KaikitaDouglas E Vaughan
Apr 25, 2003·Journal of Biomedical Science·Alice Y W ChangSamuel H H Chan
Jul 1, 2003·Indian Journal of Clinical Biochemistry : IJCB·M ChandraM K Misra
Mar 10, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·V Das-GuptaA A Pitsillides
Oct 20, 2012·Naunyn-Schmiedeberg's Archives of Pharmacology·Subramanian KumarBoobalan Raja
Apr 25, 2012·Applied Microbiology and Biotechnology·Bao-Hong Lee, Tzu-Ming Pan
Jul 9, 2010·European Journal of Applied Physiology·Anderson Saranz ZagoMichael D Brown
Feb 25, 2010·Pflügers Archiv : European journal of physiology·Hiroaki Shimokawa, Masato Tsutsui
Mar 10, 2010·Pflügers Archiv : European journal of physiology·Dragomir N SerbanPaul M Vanhoutte
Aug 11, 2010·Pflügers Archiv : European journal of physiology·Dmitriy N Atochin, Paul L Huang
Mar 7, 2009·Amino Acids·Xilong LiGuoyao Wu
Dec 25, 2012·Journal of Molecular Modeling·Bruno L OliveiraJoão D G Correia
May 1, 2007·Cardiovascular Drugs and Therapy·Vineet ChopraErdal Cavusoglu
Sep 29, 2011·Cardiovascular Drugs and Therapy·Sona MitraJawahar L Mehta
Jun 19, 2013·Documenta Ophthalmologica. Advances in Ophthalmology·Rachel M GriffithJames D Akula
Jul 16, 2003·Sleep & Breathing = Schlaf & Atmung·James S J Haight, Per Gisle Djupesland
Apr 5, 2001·Current Atherosclerosis Reports·J P Cooke, R K Oka
Jun 1, 2010·Current Atherosclerosis Reports·Joshua Liao, John A Farmer
Dec 21, 2000·Current Atherosclerosis Reports·M MaytinJ Loscalzo
Jul 18, 2003·Current Diabetes Reports·Michelle A VincentMichael J Quon
Jun 20, 2012·Current Heart Failure Reports·Matthew S Alkaitis, Mark J Crabtree
Sep 12, 2000·Current Hypertension Reports·Y ChuD D Heistad
Jan 18, 2003·Current Hypertension Reports·Aroon D Hingorani
Nov 5, 2003·Current Hypertension Reports·Paul L Huang
Feb 3, 2005·Current Hypertension Reports·Ivonne H SchulmanLeopoldo Raij
Mar 8, 2005·Current Hypertension Reports·Alessia Fornoni, Leopoldo Raij
Jan 17, 2009·Current Hypertension Reports·Ivonne Hernandez Schulman, Ming-Sheng Zhou
Dec 13, 2012·Current Hypertension Reports·Robrecht ThoonenEmmanuel S Buys
Sep 12, 2000·Current Hypertension Reports·A P Zou, A W Cowley
Sep 12, 2000·Current Hypertension Reports·K T TanC C Liew
Sep 12, 2000·Current Hypertension Reports·R Busse, I Fleming

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.